Basit öğe kaydını göster

Clinical significance of serum interleukin-17 levels in colorectal cancer patients

dc.contributor.authorKilic, Leyla
dc.contributor.authorKarabulut, Senem
dc.contributor.authorKones, Osman
dc.contributor.authorAykan, Nuri Faruk
dc.contributor.authorBilgin, Elif
dc.contributor.authorAfsar, Cigdem Usul
dc.contributor.authorKarabulut, Mehmet
dc.contributor.authorAlis, Halil
dc.date.accessioned2021-03-03T20:14:33Z
dc.date.available2021-03-03T20:14:33Z
dc.date.issued2016
dc.identifier.citationKarabulut S., Afsar C. U. , Karabulut M., Kilic L., Alis H., Kones O., Bilgin E., Aykan N. F. , "Clinical significance of serum interleukin-17 levels in colorectal cancer patients", JOURNAL OF BUON, cilt.21, sa.5, ss.1137-1145, 2016
dc.identifier.issn1107-0625
dc.identifier.othervv_1032021
dc.identifier.otherav_58e94e54-66b5-4d7a-8aad-59722a12952b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/62565
dc.description.abstractPurpose: The proinflammatory cytokine, interleukin-17 (IL-17) plays a potent role in T-cell mediated angiogenesis and promotes tumorigenicity. The objective of this study was to determine the clinical outcomes of colorectal cancer (CRC) patients in relation to serum IL-17 levels.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleClinical significance of serum interleukin-17 levels in colorectal cancer patients
dc.typeMakale
dc.relation.journalJOURNAL OF BUON
dc.contributor.departmentIstanbul Training & Research Hospital , ,
dc.identifier.volume21
dc.identifier.issue5
dc.identifier.startpage1137
dc.identifier.endpage1145
dc.contributor.firstauthorID234841


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster